RIPE-KG · Version 1.1.0 · Resource

ripekg:work/10.1038%2Fs41571-021-00524-x

https://w3id.org/ripe/ripe-kg/work/10.1038%2Fs41571-021-00524-x
SubjectPredicateObject
ripekg:work/10.1038%2Fs41571-021-00524-xNasopharyngeal carcinoma: an evolving paradigm prism:doi 10.1038/s41571-021-00524-x
ripekg:work/10.1038%2Fs41571-021-00524-xNasopharyngeal carcinoma: an evolving paradigm dcterms:title Nasopharyngeal carcinoma: an evolving paradigm
ripekg:work/10.1038%2Fs41571-021-00524-xNasopharyngeal carcinoma: an evolving paradigm rdf:type node1
ripekg:work/10.1038%2Fs41571-021-00524-xNasopharyngeal carcinoma: an evolving paradigm rdf:type http://purl.org/spar/fabio/Work
ripekg:work/10.1038%2Fs41571-021-00524-xNasopharyngeal carcinoma: an evolving paradigm rdf:type rdfs:Resource
ripekg:work/10.1038%2Fs41571-021-00524-xNasopharyngeal carcinoma: an evolving paradigm rdf:type owl:Thing
ripekg:work/10.1038%2Fs41571-021-00524-xNasopharyngeal carcinoma: an evolving paradigm rdf:type prov:Entity
ripekg:work/10.1038%2Fs41571-021-00524-xNasopharyngeal carcinoma: an evolving paradigm rdf:type ripe:WorkWork
ripekg:work/10.1038%2Fs41571-021-00524-xNasopharyngeal carcinoma: an evolving paradigm owl:sameAs https://semopenalex.org/work/W34194007
ripekg:work/10.1136%2Fbmj-2024-081557Four cycles of docetaxel plus cisplatin as neoadjuvant chemotherapy followed by concurrent chemoradiotherapy in stage N2-3 nasopharyngeal carcinoma: phase 3 multicentre randomised controlled trial http://purl.org/spar/cito/cites ripekg:work/10.1038%2Fs41571-021-00524-xNasopharyngeal carcinoma: an evolving paradigm